Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Accurately determining a company’s long-term prospects isn’t easy, especially when sentiment is weak. That’s where StockStory comes in - to help you find attractive investment candidates backed by unbiased research. Keeping that in mind, here are three stocks where the skepticism is well-placed and some better opportunities to consider.
Polaris (PII)
Consensus Price Target: $72.73 (6.4% implied return)
Founded in 1954, Polaris (NYSE:PII) designs and manufactures high-performance off-road vehicles, snowmobiles, and motorcycles.
Why Are We Bearish on PII?
- Sales were flat over the last five years, indicating it’s failed to expand its business
- Low free cash flow margin of 3.4% for the last two years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders
- Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value
Polaris’s stock price of $68.33 implies a valuation ratio of 24.8x forward P/E. Read our free research report to see why you should think twice about including PII in your portfolio.
Neogen (NEOG)
Consensus Price Target: $13 (11.4% implied return)
Founded in 1981 and operating at the intersection of food safety and animal health, Neogen (NASDAQ:NEOG) develops and manufactures diagnostic tests and related products to detect dangerous substances in food and pharmaceuticals for animal health.
Why Do We Think NEOG Will Underperform?
- Annual sales declines of 3% for the past two years show its products and services struggled to connect with the market during this cycle
- Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value
- 6× net-debt-to-EBITDA ratio makes lenders less willing to extend additional capital, potentially necessitating dilutive equity offerings
Neogen is trading at $11.67 per share, or 37.6x forward P/E. To fully understand why you should be careful with NEOG, check out our full research report (it’s free).
Seacoast Banking (SBCF)
Consensus Price Target: $37.04 (3.5% implied return)
Founded during the Florida land boom of 1926 and surviving the Great Depression, Seacoast Banking Corporation of Florida (NASDAQ:SBCF) is a financial holding company that provides commercial and retail banking, wealth management, and mortgage services throughout Florida.
Why Does SBCF Give Us Pause?
- Performance over the past five years shows its incremental sales were less profitable as its earnings per share were flat
- Tangible book value per share tumbled by 1.6% annually over the last five years, showing banking sector trends are working against it during this cycle
- Underwhelming 6.5% return on equity reflects management’s difficulties in finding profitable growth opportunities
At $35.80 per share, Seacoast Banking trades at 1.3x forward P/B. Dive into our free research report to see why there are better opportunities than SBCF.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.